Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
This report contains market size and forecasts of Viscosupplementation for Knee Osteoarthritis in global, including the following market information:
Global Viscosupplementation for Knee Osteoarthritis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Viscosupplementation for Knee Osteoarthritis Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Viscosupplementation for Knee Osteoarthritis companies in 2021 (%)
The global Viscosupplementation for Knee Osteoarthritis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viscosupplementation for Knee Osteoarthritis include Sanofi, Anika Therapeutics, Seikagaku, Zimmer, Bioventus, Ferring, Lifecore Biomedical and LG Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viscosupplementation for Knee Osteoarthritis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viscosupplementation for Knee Osteoarthritis Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viscosupplementation for Knee Osteoarthritis Market Segment Percentages, by Type, 2021 (%)
Single Injection
Three Injection
Five Injection
Global Viscosupplementation for Knee Osteoarthritis Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viscosupplementation for Knee Osteoarthritis Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Viscosupplementation for Knee Osteoarthritis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viscosupplementation for Knee Osteoarthritis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viscosupplementation for Knee Osteoarthritis revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Viscosupplementation for Knee Osteoarthritis revenues share in global market, 2021 (%)
Key companies Viscosupplementation for Knee Osteoarthritis sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Viscosupplementation for Knee Osteoarthritis sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Anika Therapeutics
Seikagaku
Zimmer
Bioventus
Ferring
Lifecore Biomedical
LG Life Sciences